Medical thoracoscopy

Current Opinion in Pulmonary Medicine

Volumn 15, Issue 4, 2009, Pages 313-320

  Casal, Roberto F ^a   Eapen, Georgie A ^a   Morice, Rodolfo C ^a   Jimenez, Carlos A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer; Lung cancer; Medical thoracoscopy; Pleural effusion; Pleuroscopy

Indexed keywords

TALC;

ADULT RESPIRATORY DISTRESS SYNDROME; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENERAL ANESTHESIA; HUMAN; INDWELLING CATHETER; LUNG CANCER; PLEURA EFFUSION; PLEURA METASTASIS; PLEURODESIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; THORACOCENTESIS; THORACOSCOPE; THORACOSCOPY; THORAX DRAINAGE; VIDEO ASSISTED THORACOSCOPIC SURGERY;

HUMANS; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; PROGNOSIS; THORACIC NEOPLASMS; THORACOSCOPES; THORACOSCOPY;

EID: 67449099500     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32832b8b2d     Document Type: Review

References (92)

1. Canto A, Blasco E, Casillas M, et al. Thoracoscopy in the diagnosis of pleural effusion. Thorax 1977; 32:550-554.
2. Rodriguez-Panadero F. Medical thoracoscopy. Respiration 2008; 76:363-372.
3. Rodriguez-Panadero F, Janssen JP, Astoul P. Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. Eur Respir J 2006; 28:409-422. (Pubitemid 44920002)
4. Lee P, Colt HG. State of the art: pleuroscopy. J Thorac Oncol 2007; 2:663-670. (Pubitemid 47171792)
5. Loddenkemper R. Thoracoscopy: state of the art. Eur Respir J 1998; 11:213-221.
6. Lee YC, Light RW. Management of malignant pleural effusions. Respirology 2004; 9:148-156. (Pubitemid 38937386)
7. Maskell NA, Butland RJ. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 2003; 58 (Suppl 2):ii8-ii17. (Pubitemid 36561104)
8. Tassi G, Marchetti G. Minithoracoscopy: a less invasive approach to thoracoscopy. Chest 2003; 124:1975-1977. (Pubitemid 37433599)
9. Janssen JP, Thunnissen F, Visser F. Comparison of the 2.0 mm and the 3.5 mm minithoracoscopy set to standard equipment for medical thoracoscopy. Eur Respir J 2003; Suppl 45:S451.
10. Lee P, Colt HG. Rigid and semirigid pleuroscopy: the future is bright. Respirology 2005; 10:418-425. (Pubitemid 43942609)
11. Harris RJ, Kavuru MS, Mehta AC, et al. The impact of thoracoscopy on the management of pleural disease. Chest 1995; 107:845-852.
12. Migliore M, Giuliano R, Aziz T, et al. Four-step local anesthesia and sedation for thoracoscopic diagnosis and management of pleural diseases. Chest 2002; 121:2032-2035. (Pubitemid 34634430)
13. Aelony Y, Boutin C. Local anesthesia with thoracoscopic talc poudrage pleurodesis. Chest 1996; 110:1126-1127. (Pubitemid 26347644)
14. Menzies R, Charbonneau M. Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med 1991; 114:271-276.
15. Oldenburg FA Jr, Newhouse MT. Thoracoscopy. A safe, accurate diagnostic procedure using the rigid thoracoscope and local anesthesia. Chest 1979; 75:45-50. (Pubitemid 9121371)
16. Danby CA, Adebonojo SA, Moritz DM. Video-assisted talc pleurodesis for malignant pleural effusions utilizing local anesthesia and I.V. sedation. Chest 1998; 113:739-742. (Pubitemid 28130951)
17. Canto A, Rivas J, Saumench J, et al. Points to consider when choosing a biopsy method in cases of pleurisy of unknown origin. Chest 1983; 84:176-179.
18. Boutin C, Vialliat J, Aelony Y. Practical thoracoscopy. Berlin: Springer Verlag; 1991.
19. Villanueva AG, Gray AW Jr, Shahian DM, et al. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 1994; 49:23-25. (Pubitemid 24118890)
20. Goodman A, Davies CW. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial. Lung Cancer 2006; 54:51-55.
21. Antony VB, Loddenkemper R, Astoul P, et al. Management of malignant pleural effusions. Eur Respir J 2001; 18:402-419. (Pubitemid 32776419)
22. Antunes G, Neville E, Duffy J, et al. BTS guidelines for the management of malignant pleural effusions. Thorax 2003; 58 (Suppl 2):ii29-ii38. (Pubitemid 36561106)
23. Ferrer J, Roldan J., Teixidor J, et al. Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy. Chest 2005; 127:1017-1022. (Pubitemid 40775535)
24. Marel M, Zrustova M, Stasny B, Light RW, et al. The incidence of pleural effusion in a well defined region. Epidemiologic study in central Bohemia. Chest 1993; 104:1486-1489.
25. Valdes L, Alvarez D, Valle JM, et al. The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest 1996; 109:158-162.
26. Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J 1997; 10:1907-1913. (Pubitemid 27368388)
27. Porcel JM, Alvarez M, Salud A, Vives M. Should a cytologic study be ordered in transudative pleural effusions? Chest 1999; 116:1836-1837.
28. Rodriguez-Panadero F, Borderas Naranjo F, Lopez Mejias J. Benign pleural effusions in cancer patients. Frequency and etiopathogenio mechanism in a series of autopsy cases. Rev Clin Esp 1988; 183:311-312.
29. Khaleeq G, Musani AI. Emerging paradigms in the management of malignant pleural effusions. Respir Med 2008; 102:939-948.
30. Postmus PE, Brambilla E, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007; 2:686-693. The International Association for the Study of Lung Cancer proposes to change the TNM classification and consider patients with MPE as M1 disease due to their poor survival rate. (Pubitemid 47357520)
31. Legha SS, Muggia FM. Pleural mesothelioma: clinical features and therapeutic implications. Ann Intern Med 1977; 87:613-621. (Pubitemid 8223614)
32. Loddenkemper R, Grosser H, Gabler A, et al. Prospective evaluation of biopsy methods in the diagnosis of malignant pleural effusions. Intrapatient comparison between pleural fluid cytology, blind needle biopsy and thoracoscopy. Am Rev Respir Dis 1983; 127 (Suppl. 4):114.
33. Chung CL, Chen YC, Chang SC. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chest 2003; 123:1188-1195. (Pubitemid 36444377)
34. Poe RH, Israel RH, Utell MJ, et al. Sensitivity, specificity, and predictive values of closed pleural biopsy. Arch Intern Med 1984; 144:325-328. (Pubitemid 14186825)
35. Boutin C, Cargnino P, Viallat JR. Thoracoscopy in the early diagnosis of malignant pleural effusions. Endoscopy 1980; 12:155-160. (Pubitemid 10046440)
36. Weissberg D, Kaufman M, Zurkowski Z. Pleuroscopy in patients with pleural effusion and pleural masses. Ann Thorac Surg 1980; 29:205-208. (Pubitemid 10134270)
37. Mouchantaf F, Villanueva AG. The long-term prognosis of patients with the diagnosis of nonmalignant pleural effusions after pleuroscopy. J Bronchol Intervent Pulmonol 2009; 16:25-27. This retrospective review showed that patients with the diagnosis of nonmalignant pleural effusion after medical thoracoscopy are highly unlikely to develop one during at least the following 3 years.
38. Ernst A, Hersh CP, Herth F, et al. A novel instrument for the evaluation of the pleural space: an experience in 34 patients. Chest 2002; 122:1530-1534. (Pubitemid 35366060)
39. Munavvar M, Khan MA, Edwards J, et al. The autoclavable semirigid thoracoscope: the way forward in pleural disease? Eur Respir J 2007; 29:571-574. In this prospective study of semirigid thoracoscopy in patients with unilateral pleural effusion of unknown cause, a specific diagnosis was obtained in 91% of the cases.
40. Lee P, Hsu A, Lo C, Colt HG. Prospective evaluation of flex-rigid pleuroscopy for indeterminate pleural effusion: accuracy, safety and outcome. Respirology 2007; 12:881-886. A prospective study on accuracy, safety, and outcome of semirigid thoracoscopy for the diagnosis of pleural effusions of indeterminate origin was performed. High diagnostic accuracy (96%) and low risk were reported. (Pubitemid 350045712)
41. Wang Z, Tong ZH, Li HJ, et al. Semi-rigid thoracoscopy for undiagnosed exudative pleural effusions: a comparative study. Chin Med J (Engl) 2008; 121:1384-1389.
42. Price B, Ware A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol 2004; 159:107-112.
43. West SD, Lee YC. Management of malignant pleural mesothelioma. Clin Chest Med 2006; 27:335-354. (Pubitemid 43729178)
44. Renshaw AA, Dean BR, Antman KH, et al. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 1997; 111:106-109. (Pubitemid 27043616)
45. Edge JR, Choudhury SL. Malignant mesothelioma of the pleura in Barrow-in-Furness. Thorax 1978; 33:26-30.
46. Boutin C, Rey F, Gouvernet J, et al. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: prognosis and staging. Cancer 1993; 72:394-404. (Pubitemid 23193443)
47. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest 1995; 108:754-758.
48. Greillier L, Cavailles A, Fraticelli A, et al. Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma. Cancer 2007; 110:2248-2252. (Pubitemid 350100747)
49. Ruckdeschel JC. Management of malignant pleural effusions. Semin Oncol 1995; 22 (2 Suppl 3):58-63.
50. Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest 2000; 117:73-78. (Pubitemid 30053623)
51. Bielsa S, Martin-Juan J, Porcel JM, Rodriguez-Panadero F. Diagnostic and prognostic implications of pleural adhesions in malignant effusions. J Thorac Oncol 2008; 3:1251-1256. This retrospective analysis suggests that in patients with MPE, the higher the degree of pleural adhesions found on thoracoscopy the worse the prognosis.
52. Chen H, Brahmer J. Management of malignant pleural effusion. Curr Oncol Rep 2008; 10:287-293.
53. Livingston RB, McCracken JD, Trauth CJ, Chen T. Isolated pleural effusion in small cell lung carcinoma: favorable prognosis. A review of the Southwest Oncology Group experience. Chest 1982; 81:208-211.
54. Heffner JE, Klein JS. Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc 2008; 83:235-250. (Pubitemid 351303104)
55. Celikoglu F, Teirstein AS, Krellenstein DJ, Strauchen JA. Pleural effusion in non-Hodgkin's lymphoma. Chest 1992; 101:1357-1360.
56. Marom EM, Patz EF Jr, Erasmus JJ, et al. Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology 1999; 210:277-281. (Pubitemid 29004316)
57. Schulze M, Boehle AS, Kurdow R, et al. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann Thorac Surg 2001; 71:1809-1812. (Pubitemid 32554405)
58. Jones GR. Treatment of recurrent malignant pleural effusion by iodized talc pleurodesis. Thorax 1969; 24:69-73.
59. Bernard A, de Dompsure RB, Hagry O, Favre JP. Early and late mortality after pleurodesis for malignant pleural effusion. Ann Thorac Surg 2002; 74:213-217. (Pubitemid 34734673)
60. Dresler CM, Olak J, Herndon JE 2nd, et al. Phase III intergroup study of talc poudrage vs. talc slurry sclerosis for malignant pleural effusion. Chest 2005; 127:909-915.
61. Stefani A, Natali P, Casali C, Morandi U. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study. Eur J Cardiothorac Surg 2006; 30:827-832. (Pubitemid 44738626)
62. Tan C, Sedrakyan A, Browne J, et al. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg 2006; 29:829-838.
63. Yim AP, Chan AT, Lee TW, et al. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg 1996; 62:1655-1658. (Pubitemid 26421097)
64. Porcel JM, Salud A, Nabal M, et al. Rapid pleurodesis with doxycycline through a small-bore catheter for the treatment of metastatic malignant effusions. Support Care Cancer 2006; 14:475-478.
65. Heffner JE, Standerfer RJ, Torstveit J, Unruh L. Clinical efficacy of doxycycline for pleurodesis. Chest 1994; 105:1743-1747. (Pubitemid 24180662)
66. Kuzdzal J, Sladek K, Wasowski D, et al. Talc powder vs. doxycycline in the control of malignant pleural effusion: a prospective, randomized trial. Med Sci Monit 2003; 9:PI54-PI59. (Pubitemid 36850717)
67. Haddad FJ, Younes RN, Gross JL, Deheinzelin D. Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial. World J Surg 2004; 28:749-753. [discussion 753-754]. (Pubitemid 39315388)
68. Kilic D, Akay H, Kavukcu S, et al. Management of recurrent malignant pleural effusion with chemical pleurodesis. Surg Today 2005; 35:634-638. (Pubitemid 41032282)
69. Agarwal R. Iodopovidone: an inexpensive and effective agent for chemical pleurodesis. Lung Cancer 2007; 55:253-254. (Pubitemid 46074230)
70. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 2004(1):CD002916.
71. Manes N, Rodriguez Panadero F, Bravo JL, et al. Talc pleurodesis. Prospective and randomized study. Clinical follow-up. Chest 2000; 118:131s.
72. Jimenez CA, Mhatre AD, Martinez CH, et al. Use of an indwelling pleural catheter for the management of recurrent chylothorax in patients with cancer. Chest 2007; 132:1584-1590. (Pubitemid 350156016)
73. Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 2006; 129:362-368. (Pubitemid 43289856)
74. Putnam JB Jr, Light RW, Rodriguez RM, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999; 86:1992-1999.
75. Putnam JB Jr, Walsh GL, Swisher SG, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 2000; 69:369-375. (Pubitemid 30125561)
76. Tremblay A, Mason C, Michaud G. Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis. Eur Respir J 2007; 30:759-762. (Pubitemid 351194838)
77. Viskum K, Enk B. Complications of thoracoscopy. Poumon Coeur 1981; 37:25-28. (Pubitemid 11086399)
78. Burgers S. Medical thoracoscopy. In Simoff M, Sterman DH, Ernst A, editors. Thoracic endoscopy. Blackwell Futura; 2006. pp. 224-241.
79. Viallat JR, Rey F, Astoul P, Boutin C. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest 1996; 110: 1387-1393. (Pubitemid 26425133)
80. Weissberg D, Refaely Y. Pleural empyema: 24-year experience. Ann Thorac Surg 1996; 62:1026-1029. (Pubitemid 26340317)
81. de Campos JR, Vargas FS, de Campos Werebe E, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest 2001; 119:801-806. (Pubitemid 32197651)
82. Boutin C, Viallat JR, Cargnino P, Farisse P. Thoracoscopy in malignant pleural effusions. Am Rev Respir Dis 1981; 124:588-592. (Pubitemid 12236685)
83. Jensen MO, Matthees DJ, Antonenko D. Laser thoracoscopy for pleural effusion. Am Surg 1992; 58:667-669.
84. Janssen JP, Collier G, Astoul P, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007; 369:1535-1539. Multicenter, open-label, prospective cohort study to evaluate the safety of thoracoscopic talc insufflation with large-particle talc in MPE. None of the 558 patients enrolled developed ARDS. (Pubitemid 46670303)
85. Aelony Y. Talc pleurodesis and acute respiratory distress syndrome. Lancet 2007; 369:1494-1496. (Pubitemid 46670287)
86. Kennedy L, Rusoh VW, Strange C, et al. Pleurodesis using talc slurry. Chest 1994; 106:342-346. (Pubitemid 24252022)
87. Rehse DH, Aye RW, Florence MG. Respiratory failure following talc pleurodesis. Am J Surg 1999; 177:437-440. (Pubitemid 29252818)
88. Campos JR, Werebe EC, Vargas FS, et al. Respiratory failure due to insufflated talc. Lancet 1997; 349:251-252. (Pubitemid 27050994)
89. Light RW. Talc should not be used for pleurodesis. Am J Respir Crit Care Med 2000; 162:2024-2026. (Pubitemid 32051656)
90. Ferrer J, Villarino MA, Tura JM, et al. Talc preparations used for pleurodesis vary markedly from one preparation to another. Chest 2001; 119:1901-1905.
91. Rinaldo JE, Owens GR, Rogers RM. Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg 1983; 85:523-526.
92. Cardillo G, Facciolo F, Carbone L, et al. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur J Cardiothorac Surg 2002; 21:302-305; discussion 305-306. (Pubitemid 34134487)